About the HZI
How do bacteria and viruses make us sick? How does our immune system defend our body? Which novel pharmaceutical compounds can help us to fight dangerous infections? These are questions we at the HZI want to answer. Our goal: To set up the basis for new diagnostic tools, new drugs and new therapies against infectious diseases.
History of the Helmholtz Centre for Infection Research
May 2012: Opening of the Study Centre in Hannover. In the future, studies about public health will be conducted here and the connections between infections and chronic diseases will be investigated.
April 2011: HZI becomes a partner of the nationwide „German Centre for Infection Research“ and will also host the principal office.
January 2011: The HZI coordinates the newly founded Centre for Structural Systems Biology (CSSB), which is built on the campus of DESY in Hamburg.
August 2009: Founding of the HZI branch on the campus of the University Saarbrücken: Scientists at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) develop new drugs and therapies against infectious diseases.
June 2009: After a construction period of little more than three years, the new animal facility is opened. In total, 30 000 mice are now hosted at HZI and taken care of by more than 50 employees.
August 2008: Together with Hannover Medical School, HZI opens the Centre for Experimental and Clinical Infection Research TWINCORE in close proximity to the MHH campus in Hannover.
July 2006: The GBF is renamed Helmholtz Centre for Infection Research. At the same time, the center's new entrance gate was completed. With it, the campus has a new driveway and a new address.
March 2006: The animal house has reached the limits of its capacity. Construction on a new house begins to make room for more than 23 000 animals.
2005: The GBF buys the adjacent building belonging to the innovation center. The purchase adds urgently needed space to house several research groups.
2000: GBF’s very own forum for meetings, congress and workshops aptly named the Forum, is opened.
1999: Medical applied biotechnology gains increasing influence during the 90’s. Since animal experiments are essential for this, a modern “Animal House” for mouse keeping is established, focusing on vaccine research.
1997: The GBF is granted the right to produce pharmaceutical agents for use in medical care. “Good Manufacturing Practice” (GMP) quality assurance is applied to the new plant.
1976: The German Research Centre for Biotechnology (GBF) is the result.
1975/76: The Federal Republic of Germany obtains control of the institute, and the state of Lower Saxony joins as partner.
1975: The “Biotechnikum” research and development facility is put on line, changing the focus from basic research in molecular biology to application oriented biotechnology.
1968: Aided by the Volkswagen-Foundation, the IMB is turned into the Gesellschaft für Molekularbiologische Forschung mbH (GMBF).
1965: The Centre´s predecessor is founded, the Institute of Molecular Biology, Biochemistry and Biophysics (IMB), initiated by the chemist Prof. Dr. Hans Herloff Inhoffen. Inhoffen is supported by several scientists of note, especially Nobel award winner Prof. Dr. Manfred Eigen.